Search

Search Constraints

You searched for: Author/Creator Basnet, S.

Search Results

4. 50P Enhancing TIL and NK cells adoptive therapies with an engineered oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer. (December 2022)

5. 52P MUC1 targeted immunotherapy with an oncolytic adenovirus coding for a bispecific T cell engager. (December 2022)